EP Patent

EP1711178A1 — Compositions substantially free of galactomannan containing piperacillin and tazobactam

Assigned to Wyeth LLC · Expires 2006-10-18 · 20y expired

What this patent protects

The invention pertains to pharmaceutical compositions of Zosyn® having substantially free or reduced levels of galactomannan and processes to prepare said pharmaceutical compositions.

USPTO Abstract

The invention pertains to pharmaceutical compositions of Zosyn® having substantially free or reduced levels of galactomannan and processes to prepare said pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number: EP1711178A1
Jurisdiction: EP
Classification: —
Expires: 2006-10-18
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.